nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ABCB1—peripheral nervous system neoplasm	0.428	1	CbGaD
Liotrix—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0544	0.224	CbGbCtD
Liotrix—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0396	0.163	CbGbCtD
Liotrix—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0396	0.163	CbGbCtD
Liotrix—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0275	0.113	CbGbCtD
Liotrix—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0229	0.0943	CbGbCtD
Liotrix—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0169	0.0697	CbGbCtD
Liotrix—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0158	0.065	CbGbCtD
Liotrix—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0155	0.0638	CbGbCtD
Liotrix—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0106	0.0435	CbGbCtD
Liotrix—Levothyroxine—ABCB1—peripheral nervous system neoplasm	0.00109	0.584	CrCbGaD
Liotrix—Liothyronine—ABCB1—peripheral nervous system neoplasm	0.000775	0.416	CrCbGaD
Liotrix—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000274	0.000838	CcSEcCtD
Liotrix—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000273	0.000834	CcSEcCtD
Liotrix—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000272	0.000832	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000272	0.00083	CcSEcCtD
Liotrix—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000829	CcSEcCtD
Liotrix—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000829	CcSEcCtD
Liotrix—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00027	0.000825	CcSEcCtD
Liotrix—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00027	0.000825	CcSEcCtD
Liotrix—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00027	0.000824	CcSEcCtD
Liotrix—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000269	0.000822	CcSEcCtD
Liotrix—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000819	CcSEcCtD
Liotrix—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000268	0.000818	CcSEcCtD
Liotrix—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.000815	CcSEcCtD
Liotrix—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.000809	CcSEcCtD
Liotrix—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000264	0.000806	CcSEcCtD
Liotrix—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000264	0.000806	CcSEcCtD
Liotrix—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000264	0.000806	CcSEcCtD
Liotrix—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000264	0.000806	CcSEcCtD
Liotrix—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000801	CcSEcCtD
Liotrix—Infection—Cisplatin—peripheral nervous system neoplasm	0.000262	0.000801	CcSEcCtD
Liotrix—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000262	0.0008	CcSEcCtD
Liotrix—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000798	CcSEcCtD
Liotrix—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000798	CcSEcCtD
Liotrix—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000798	CcSEcCtD
Liotrix—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00026	0.000795	CcSEcCtD
Liotrix—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000795	CcSEcCtD
Liotrix—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00026	0.000793	CcSEcCtD
Liotrix—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00026	0.000793	CcSEcCtD
Liotrix—Rash—Topotecan—peripheral nervous system neoplasm	0.000259	0.000793	CcSEcCtD
Liotrix—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000259	0.000792	CcSEcCtD
Liotrix—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000259	0.000792	CcSEcCtD
Liotrix—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000789	CcSEcCtD
Liotrix—Headache—Topotecan—peripheral nervous system neoplasm	0.000258	0.000788	CcSEcCtD
Liotrix—Rash—Tretinoin—peripheral nervous system neoplasm	0.000257	0.000787	CcSEcCtD
Liotrix—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000257	0.000787	CcSEcCtD
Liotrix—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000257	0.000786	CcSEcCtD
Liotrix—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000257	0.000786	CcSEcCtD
Liotrix—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000257	0.000786	CcSEcCtD
Liotrix—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000257	0.000786	CcSEcCtD
Liotrix—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000256	0.000784	CcSEcCtD
Liotrix—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000256	0.000783	CcSEcCtD
Liotrix—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000783	CcSEcCtD
Liotrix—Headache—Tretinoin—peripheral nervous system neoplasm	0.000256	0.000782	CcSEcCtD
Liotrix—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000256	0.000782	CcSEcCtD
Liotrix—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000255	0.000781	CcSEcCtD
Liotrix—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.000779	CcSEcCtD
Liotrix—Constipation—Vincristine—peripheral nervous system neoplasm	0.000255	0.000779	CcSEcCtD
Liotrix—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000255	0.000779	CcSEcCtD
Liotrix—Rash—Melphalan—peripheral nervous system neoplasm	0.000254	0.000777	CcSEcCtD
Liotrix—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000254	0.000776	CcSEcCtD
Liotrix—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000253	0.000773	CcSEcCtD
Liotrix—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000252	0.00077	CcSEcCtD
Liotrix—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000251	0.000768	CcSEcCtD
Liotrix—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000767	CcSEcCtD
Liotrix—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000766	CcSEcCtD
Liotrix—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000753	CcSEcCtD
Liotrix—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000246	0.000752	CcSEcCtD
Liotrix—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.000751	CcSEcCtD
Liotrix—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.000748	CcSEcCtD
Liotrix—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.000748	CcSEcCtD
Liotrix—Nausea—Topotecan—peripheral nervous system neoplasm	0.000244	0.000747	CcSEcCtD
Liotrix—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000244	0.000745	CcSEcCtD
Liotrix—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000244	0.000744	CcSEcCtD
Liotrix—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000743	CcSEcCtD
Liotrix—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000242	0.000741	CcSEcCtD
Liotrix—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000242	0.000741	CcSEcCtD
Liotrix—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000741	CcSEcCtD
Liotrix—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000241	0.000738	CcSEcCtD
Liotrix—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000738	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00024	0.000734	CcSEcCtD
Liotrix—Infection—Etoposide—peripheral nervous system neoplasm	0.00024	0.000733	CcSEcCtD
Liotrix—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000733	CcSEcCtD
Liotrix—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000239	0.000732	CcSEcCtD
Liotrix—Nausea—Melphalan—peripheral nervous system neoplasm	0.000239	0.000732	CcSEcCtD
Liotrix—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.00073	CcSEcCtD
Liotrix—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000728	CcSEcCtD
Liotrix—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000725	CcSEcCtD
Liotrix—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000237	0.000724	CcSEcCtD
Liotrix—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000236	0.000721	CcSEcCtD
Liotrix—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000236	0.00072	CcSEcCtD
Liotrix—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000236	0.00072	CcSEcCtD
Liotrix—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000235	0.000718	CcSEcCtD
Liotrix—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000233	0.000714	CcSEcCtD
Liotrix—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000709	CcSEcCtD
Liotrix—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000709	CcSEcCtD
Liotrix—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00023	0.000704	CcSEcCtD
Liotrix—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000229	0.000701	CcSEcCtD
Liotrix—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000229	0.0007	CcSEcCtD
Liotrix—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000228	0.000698	CcSEcCtD
Liotrix—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000228	0.000697	CcSEcCtD
Liotrix—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000226	0.00069	CcSEcCtD
Liotrix—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000687	CcSEcCtD
Liotrix—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.000679	CcSEcCtD
Liotrix—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000678	CcSEcCtD
Liotrix—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000673	CcSEcCtD
Liotrix—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00022	0.000671	CcSEcCtD
Liotrix—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.000669	CcSEcCtD
Liotrix—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000217	0.000664	CcSEcCtD
Liotrix—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000217	0.000663	CcSEcCtD
Liotrix—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000658	CcSEcCtD
Liotrix—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000215	0.000658	CcSEcCtD
Liotrix—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000656	CcSEcCtD
Liotrix—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000214	0.000654	CcSEcCtD
Liotrix—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000212	0.000649	CcSEcCtD
Liotrix—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000648	CcSEcCtD
Liotrix—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.000647	CcSEcCtD
Liotrix—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00021	0.000643	CcSEcCtD
Liotrix—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00021	0.000642	CcSEcCtD
Liotrix—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000638	CcSEcCtD
Liotrix—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000208	0.000637	CcSEcCtD
Liotrix—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000208	0.000636	CcSEcCtD
Liotrix—Constipation—Etoposide—peripheral nervous system neoplasm	0.000207	0.000631	CcSEcCtD
Liotrix—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.000625	CcSEcCtD
Liotrix—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000204	0.000624	CcSEcCtD
Liotrix—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000622	CcSEcCtD
Liotrix—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000609	CcSEcCtD
Liotrix—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000199	0.000608	CcSEcCtD
Liotrix—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000198	0.000606	CcSEcCtD
Liotrix—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000197	0.000604	CcSEcCtD
Liotrix—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000197	0.000603	CcSEcCtD
Liotrix—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000601	CcSEcCtD
Liotrix—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.000596	CcSEcCtD
Liotrix—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.000596	CcSEcCtD
Liotrix—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000194	0.000594	CcSEcCtD
Liotrix—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.000592	CcSEcCtD
Liotrix—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00059	CcSEcCtD
Liotrix—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000192	0.000586	CcSEcCtD
Liotrix—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000191	0.000584	CcSEcCtD
Liotrix—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000191	0.000584	CcSEcCtD
Liotrix—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00058	CcSEcCtD
Liotrix—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00019	0.000579	CcSEcCtD
Liotrix—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000189	0.000578	CcSEcCtD
Liotrix—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000576	CcSEcCtD
Liotrix—Rash—Vincristine—peripheral nervous system neoplasm	0.000188	0.000575	CcSEcCtD
Liotrix—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000188	0.000574	CcSEcCtD
Liotrix—Headache—Vincristine—peripheral nervous system neoplasm	0.000187	0.000571	CcSEcCtD
Liotrix—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000562	CcSEcCtD
Liotrix—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00018	0.000551	CcSEcCtD
Liotrix—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000178	0.000544	CcSEcCtD
Liotrix—Nausea—Vincristine—peripheral nervous system neoplasm	0.000177	0.000541	CcSEcCtD
Liotrix—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000541	CcSEcCtD
Liotrix—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000536	CcSEcCtD
Liotrix—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000173	0.00053	CcSEcCtD
Liotrix—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000171	0.000522	CcSEcCtD
Liotrix—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00052	CcSEcCtD
Liotrix—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000515	CcSEcCtD
Liotrix—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000512	CcSEcCtD
Liotrix—Rash—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000508	CcSEcCtD
Liotrix—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000508	CcSEcCtD
Liotrix—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000165	0.000505	CcSEcCtD
Liotrix—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.0005	CcSEcCtD
Liotrix—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000163	0.0005	CcSEcCtD
Liotrix—Tension—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000498	CcSEcCtD
Liotrix—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000497	CcSEcCtD
Liotrix—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000492	CcSEcCtD
Liotrix—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00016	0.000488	CcSEcCtD
Liotrix—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000481	CcSEcCtD
Liotrix—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000479	CcSEcCtD
Liotrix—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000478	CcSEcCtD
Liotrix—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000476	CcSEcCtD
Liotrix—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000154	0.000469	CcSEcCtD
Liotrix—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000466	CcSEcCtD
Liotrix—Rash—Etoposide—peripheral nervous system neoplasm	0.000152	0.000465	CcSEcCtD
Liotrix—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000152	0.000465	CcSEcCtD
Liotrix—Headache—Etoposide—peripheral nervous system neoplasm	0.000151	0.000462	CcSEcCtD
Liotrix—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000462	CcSEcCtD
Liotrix—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00046	CcSEcCtD
Liotrix—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000459	CcSEcCtD
Liotrix—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000456	CcSEcCtD
Liotrix—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000455	CcSEcCtD
Liotrix—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000448	CcSEcCtD
Liotrix—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000446	CcSEcCtD
Liotrix—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000442	CcSEcCtD
Liotrix—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000439	CcSEcCtD
Liotrix—Nausea—Etoposide—peripheral nervous system neoplasm	0.000143	0.000439	CcSEcCtD
Liotrix—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000438	CcSEcCtD
Liotrix—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000432	CcSEcCtD
Liotrix—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000432	CcSEcCtD
Liotrix—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000431	CcSEcCtD
Liotrix—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00043	CcSEcCtD
Liotrix—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000421	CcSEcCtD
Liotrix—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000417	CcSEcCtD
Liotrix—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000415	CcSEcCtD
Liotrix—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000414	CcSEcCtD
Liotrix—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000414	CcSEcCtD
Liotrix—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000412	CcSEcCtD
Liotrix—Infection—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000411	CcSEcCtD
Liotrix—Shock—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000407	CcSEcCtD
Liotrix—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000407	CcSEcCtD
Liotrix—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000405	CcSEcCtD
Liotrix—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000404	CcSEcCtD
Liotrix—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000131	0.0004	CcSEcCtD
Liotrix—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000399	CcSEcCtD
Liotrix—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000399	CcSEcCtD
Liotrix—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000398	CcSEcCtD
Liotrix—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000394	CcSEcCtD
Liotrix—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000387	CcSEcCtD
Liotrix—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000386	CcSEcCtD
Liotrix—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000383	CcSEcCtD
Liotrix—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000383	CcSEcCtD
Liotrix—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00038	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000377	CcSEcCtD
Liotrix—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000377	CcSEcCtD
Liotrix—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000374	CcSEcCtD
Liotrix—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000374	CcSEcCtD
Liotrix—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000372	CcSEcCtD
Liotrix—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00037	CcSEcCtD
Liotrix—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000369	CcSEcCtD
Liotrix—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000365	CcSEcCtD
Liotrix—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000118	0.00036	CcSEcCtD
Liotrix—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000358	CcSEcCtD
Liotrix—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000357	CcSEcCtD
Liotrix—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000354	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000349	CcSEcCtD
Liotrix—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000346	CcSEcCtD
Liotrix—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000344	CcSEcCtD
Liotrix—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000341	CcSEcCtD
Liotrix—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000341	CcSEcCtD
Liotrix—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000338	CcSEcCtD
Liotrix—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000333	CcSEcCtD
Liotrix—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00033	CcSEcCtD
Liotrix—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000329	CcSEcCtD
Liotrix—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000327	CcSEcCtD
Liotrix—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000327	CcSEcCtD
Liotrix—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000327	CcSEcCtD
Liotrix—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000316	CcSEcCtD
Liotrix—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000313	CcSEcCtD
Liotrix—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000305	CcSEcCtD
Liotrix—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000304	CcSEcCtD
Liotrix—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000303	CcSEcCtD
Liotrix—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000303	CcSEcCtD
Liotrix—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000297	CcSEcCtD
Liotrix—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.58e-05	0.000293	CcSEcCtD
Liotrix—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.26e-05	0.000283	CcSEcCtD
Liotrix—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000282	CcSEcCtD
Liotrix—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000275	CcSEcCtD
Liotrix—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000274	CcSEcCtD
Liotrix—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.86e-05	0.000271	CcSEcCtD
Liotrix—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000263	CcSEcCtD
Liotrix—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000262	CcSEcCtD
Liotrix—Rash—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000261	CcSEcCtD
Liotrix—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000261	CcSEcCtD
Liotrix—Headache—Epirubicin—peripheral nervous system neoplasm	8.48e-05	0.000259	CcSEcCtD
Liotrix—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000253	CcSEcCtD
Liotrix—Nausea—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000246	CcSEcCtD
Liotrix—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.96e-05	0.000243	CcSEcCtD
Liotrix—Rash—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000241	CcSEcCtD
Liotrix—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000241	CcSEcCtD
Liotrix—Headache—Doxorubicin—peripheral nervous system neoplasm	7.85e-05	0.00024	CcSEcCtD
Liotrix—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000227	CcSEcCtD
